| 000 | 03073nam a22004455i 4500 | ||
|---|---|---|---|
| 001 | 978-1-4419-8417-3 | ||
| 003 | DE-He213 | ||
| 005 | 20140220083728.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 110504s2011 xxu| s |||| 0|eng d | ||
| 020 |
_a9781441984173 _9978-1-4419-8417-3 |
||
| 024 | 7 |
_a10.1007/978-1-4419-8417-3 _2doi |
|
| 050 | 4 | _aRC261-271 | |
| 072 | 7 |
_aMJCL _2bicssc |
|
| 072 | 7 |
_aMED062000 _2bisacsh |
|
| 082 | 0 | 4 |
_a614.5999 _223 |
| 100 | 1 |
_aJackman, Ann L. _eeditor. |
|
| 245 | 1 | 0 |
_aTargeted Drug Strategies for Cancer and Inflammation _h[electronic resource] / _cedited by Ann L. Jackman, Christopher P. Leamon. |
| 264 | 1 |
_aBoston, MA : _bSpringer US, _c2011. |
|
| 300 |
_aXI, 254 p. 69 illus., 22 illus. in color. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 505 | 0 | _aBiological Role, Properties and Therapeutic Applications of the Reduced Folate Carrier (RFC-SLC19A1) and the Proton-Coupled Folate Transporter (PCFT-SLC46A1) -- Folate Receptors and Therapeutic Applications -- Hormonal Control of Folate Receptor Genes -- Folate Receptor Targeted Radionuclide Imaging Agents -- Folate receptor targeted thymidylate synthase inhibitors -- Discovery of novel antifolate inhibitors of de novo purine nucleotide biosynthesis with selectivity for high affinity folate receptors and the proton-coupled folate transporter over the reduced folate carrier for cellular entry -- Folate-receptor targeted cancer chemotherapy -- Anti-FR antibody generation and engineering: development of new therapeutic tools -- Folate Receptor Positive Macrophages: Cellular Targets for Imaging and Therapy of Inflammatory and Autoimmune Diseases -- Targeting Activated Macrophages via a Functional Folate Receptor for Potential Treatment of Autoimmune/Inflammatory Disorders.-. | |
| 520 | _aThe discoveries highlighted in this book parallel the emergence of innovative “molecular targeted” small molecules and monoclonal antibodies, i.e. agents that target proteins within highly activated signal transduction pathways that control proliferation. Many of the tumor-targeted strategies described within cross the boundaries between what’s considered to be “molecular targeted” versus conventional systemic therapy. However, the main theme of this volume is the folate receptor (FR), with much of the content focused on its basic biology and regulation as well as its exploitation for targeted therapy and diagnostic imaging. | ||
| 650 | 0 | _aMedicine. | |
| 650 | 0 | _aOncology. | |
| 650 | 0 | _aToxicology. | |
| 650 | 1 | 4 | _aBiomedicine. |
| 650 | 2 | 4 | _aCancer Research. |
| 650 | 2 | 4 | _aPharmacology/Toxicology. |
| 700 | 1 |
_aLeamon, Christopher P. _eeditor. |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9781441984166 |
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-1-4419-8417-3 |
| 912 | _aZDB-2-SBL | ||
| 999 |
_c105992 _d105992 |
||